▶ 調査レポート

グロボイド細胞白質ジストロフィー（GLD）治療の世界市場（～2026年）
• 英文タイトル：Global Globoid Cell Leukodystrophy Treatment Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。グロボイド細胞白質ジストロフィー（GLD）治療の世界市場（～2026年） / Global Globoid Cell Leukodystrophy Treatment Market Size, Status and Forecast 2020-2026 / MRC2-11QY12059資料のイメージです。• レポートコード：MRC2-11QY12059
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア
• 販売価格（消費税別）
  Single User￥585,000 (USD3,900)▷ お問い合わせ
  Multi User￥877,500 (USD5,850)▷ お問い合わせ
  Enterprise License￥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当調査資料はグロボイド細胞白質ジストロフィー（GLD）治療のグローバル市場について調査・分析したレポートです。種類別（RND-001、CMB-200、DUOC-01、その他）市場規模、用途別（病院、クリニック、研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別グロボイド細胞白質ジストロフィー（GLD）治療の競争状況、市場シェア
・世界のグロボイド細胞白質ジストロフィー（GLD）治療市場：種類別市場規模 2015年-2020年（RND-001、CMB-200、DUOC-01、その他）
・世界のグロボイド細胞白質ジストロフィー（GLD）治療市場：種類別市場規模予測 2021年-2026年（RND-001、CMB-200、DUOC-01、その他）
・世界のグロボイド細胞白質ジストロフィー（GLD）治療市場：用途別市場規模 2015年-2020年（病院、クリニック、研究センター）
・世界のグロボイド細胞白質ジストロフィー（GLD）治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック、研究センター）
・北米のグロボイド細胞白質ジストロフィー（GLD）治療市場分析：米国、カナダ
・ヨーロッパのグロボイド細胞白質ジストロフィー（GLD）治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのグロボイド細胞白質ジストロフィー（GLD）治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のグロボイド細胞白質ジストロフィー（GLD）治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのグロボイド細胞白質ジストロフィー（GLD）治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Commence Bio Inc、Kyorin Pharmaceutical Co Ltd、Novartis AG、Nuo Therapeutics Inc
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Globoid Cell Leukodystrophy Treatment Market
The global Globoid Cell Leukodystrophy Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Globoid Cell Leukodystrophy Treatment Scope and Market Size
Globoid Cell Leukodystrophy Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Globoid Cell Leukodystrophy Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Commence Bio Inc
Kyorin Pharmaceutical Co Ltd
Novartis AG
Nuo Therapeutics Inc
…

Market segment by Type, the product can be split into
RND-001
CMB-200
DUOC-01
Others
Market segment by Application, split into
Hospital
Clinic
Research Center

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Globoid Cell Leukodystrophy Treatment Revenue
1.4 Market by Type
1.4.1 Global Globoid Cell Leukodystrophy Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 RND-001
1.4.3 CMB-200
1.4.4 DUOC-01
1.4.5 Others
1.5 Market by Application
1.5.1 Global Globoid Cell Leukodystrophy Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Research Center
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Globoid Cell Leukodystrophy Treatment Market Perspective (2015-2026)
2.2 Global Globoid Cell Leukodystrophy Treatment Growth Trends by Regions
2.2.1 Globoid Cell Leukodystrophy Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Globoid Cell Leukodystrophy Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Globoid Cell Leukodystrophy Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Globoid Cell Leukodystrophy Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Globoid Cell Leukodystrophy Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Globoid Cell Leukodystrophy Treatment Players by Market Size
3.1.1 Global Top Globoid Cell Leukodystrophy Treatment Players by Revenue (2015-2020)
3.1.2 Global Globoid Cell Leukodystrophy Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Globoid Cell Leukodystrophy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Globoid Cell Leukodystrophy Treatment Market Concentration Ratio
3.2.1 Global Globoid Cell Leukodystrophy Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Globoid Cell Leukodystrophy Treatment Revenue in 2019
3.3 Globoid Cell Leukodystrophy Treatment Key Players Head office and Area Served
3.4 Key Players Globoid Cell Leukodystrophy Treatment Product Solution and Service
3.5 Date of Enter into Globoid Cell Leukodystrophy Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Globoid Cell Leukodystrophy Treatment Historic Market Size by Type (2015-2020)
4.2 Global Globoid Cell Leukodystrophy Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Globoid Cell Leukodystrophy Treatment Market Size by Application (2015-2020)
5.2 Global Globoid Cell Leukodystrophy Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Globoid Cell Leukodystrophy Treatment Market Size (2015-2020)
6.2 Globoid Cell Leukodystrophy Treatment Key Players in North America (2019-2020)
6.3 North America Globoid Cell Leukodystrophy Treatment Market Size by Type (2015-2020)
6.4 North America Globoid Cell Leukodystrophy Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Globoid Cell Leukodystrophy Treatment Market Size (2015-2020)
7.2 Globoid Cell Leukodystrophy Treatment Key Players in Europe (2019-2020)
7.3 Europe Globoid Cell Leukodystrophy Treatment Market Size by Type (2015-2020)
7.4 Europe Globoid Cell Leukodystrophy Treatment Market Size by Application (2015-2020)

8 China
8.1 China Globoid Cell Leukodystrophy Treatment Market Size (2015-2020)
8.2 Globoid Cell Leukodystrophy Treatment Key Players in China (2019-2020)
8.3 China Globoid Cell Leukodystrophy Treatment Market Size by Type (2015-2020)
8.4 China Globoid Cell Leukodystrophy Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Globoid Cell Leukodystrophy Treatment Market Size (2015-2020)
9.2 Globoid Cell Leukodystrophy Treatment Key Players in Japan (2019-2020)
9.3 Japan Globoid Cell Leukodystrophy Treatment Market Size by Type (2015-2020)
9.4 Japan Globoid Cell Leukodystrophy Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Globoid Cell Leukodystrophy Treatment Market Size (2015-2020)
10.2 Globoid Cell Leukodystrophy Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Globoid Cell Leukodystrophy Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Globoid Cell Leukodystrophy Treatment Market Size by Application (2015-2020)

11 India
11.1 India Globoid Cell Leukodystrophy Treatment Market Size (2015-2020)
11.2 Globoid Cell Leukodystrophy Treatment Key Players in India (2019-2020)
11.3 India Globoid Cell Leukodystrophy Treatment Market Size by Type (2015-2020)
11.4 India Globoid Cell Leukodystrophy Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Globoid Cell Leukodystrophy Treatment Market Size (2015-2020)
12.2 Globoid Cell Leukodystrophy Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Globoid Cell Leukodystrophy Treatment Market Size by Type (2015-2020)
12.4 Central & South America Globoid Cell Leukodystrophy Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Commence Bio Inc
13.1.1 Commence Bio Inc Company Details
13.1.2 Commence Bio Inc Business Overview
13.1.3 Commence Bio Inc Globoid Cell Leukodystrophy Treatment Introduction
13.1.4 Commence Bio Inc Revenue in Globoid Cell Leukodystrophy Treatment Business (2015-2020))
13.1.5 Commence Bio Inc Recent Development
13.2 Kyorin Pharmaceutical Co Ltd
13.2.1 Kyorin Pharmaceutical Co Ltd Company Details
13.2.2 Kyorin Pharmaceutical Co Ltd Business Overview
13.2.3 Kyorin Pharmaceutical Co Ltd Globoid Cell Leukodystrophy Treatment Introduction
13.2.4 Kyorin Pharmaceutical Co Ltd Revenue in Globoid Cell Leukodystrophy Treatment Business (2015-2020)
13.2.5 Kyorin Pharmaceutical Co Ltd Recent Development
13.3 Novartis AG
13.3.1 Novartis AG Company Details
13.3.2 Novartis AG Business Overview
13.3.3 Novartis AG Globoid Cell Leukodystrophy Treatment Introduction
13.3.4 Novartis AG Revenue in Globoid Cell Leukodystrophy Treatment Business (2015-2020)
13.3.5 Novartis AG Recent Development
13.4 Nuo Therapeutics Inc
13.4.1 Nuo Therapeutics Inc Company Details
13.4.2 Nuo Therapeutics Inc Business Overview
13.4.3 Nuo Therapeutics Inc Globoid Cell Leukodystrophy Treatment Introduction
13.4.4 Nuo Therapeutics Inc Revenue in Globoid Cell Leukodystrophy Treatment Business (2015-2020)
13.4.5 Nuo Therapeutics Inc Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Globoid Cell Leukodystrophy Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Globoid Cell Leukodystrophy Treatment Revenue
Table 3. Ranking of Global Top Globoid Cell Leukodystrophy Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Globoid Cell Leukodystrophy Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of RND-001
Table 6. Key Players of CMB-200
Table 7. Key Players of DUOC-01
Table 8. Key Players of Others
Table 9. Global Globoid Cell Leukodystrophy Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Globoid Cell Leukodystrophy Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Globoid Cell Leukodystrophy Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Globoid Cell Leukodystrophy Treatment Market Share by Regions (2015-2020)
Table 13. Global Globoid Cell Leukodystrophy Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Globoid Cell Leukodystrophy Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Globoid Cell Leukodystrophy Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Globoid Cell Leukodystrophy Treatment Players
Table 20. Global Globoid Cell Leukodystrophy Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Globoid Cell Leukodystrophy Treatment Market Share by Players (2015-2020)
Table 22. Global Top Globoid Cell Leukodystrophy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Globoid Cell Leukodystrophy Treatment as of 2019)
Table 23. Global Globoid Cell Leukodystrophy Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Globoid Cell Leukodystrophy Treatment Product Solution and Service
Table 26. Date of Enter into Globoid Cell Leukodystrophy Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Globoid Cell Leukodystrophy Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Globoid Cell Leukodystrophy Treatment Market Size Share by Type (2015-2020)
Table 30. Global Globoid Cell Leukodystrophy Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Globoid Cell Leukodystrophy Treatment Market Size Share by Application (2015-2020)
Table 32. Global Globoid Cell Leukodystrophy Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Globoid Cell Leukodystrophy Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Globoid Cell Leukodystrophy Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Globoid Cell Leukodystrophy Treatment Market Share (2019-2020)
Table 36. North America Globoid Cell Leukodystrophy Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Globoid Cell Leukodystrophy Treatment Market Share by Type (2015-2020)
Table 38. North America Globoid Cell Leukodystrophy Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Globoid Cell Leukodystrophy Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Globoid Cell Leukodystrophy Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Globoid Cell Leukodystrophy Treatment Market Share (2019-2020)
Table 42. Europe Globoid Cell Leukodystrophy Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Globoid Cell Leukodystrophy Treatment Market Share by Type (2015-2020)
Table 44. Europe Globoid Cell Leukodystrophy Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Globoid Cell Leukodystrophy Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Globoid Cell Leukodystrophy Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Globoid Cell Leukodystrophy Treatment Market Share (2019-2020)
Table 48. China Globoid Cell Leukodystrophy Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Globoid Cell Leukodystrophy Treatment Market Share by Type (2015-2020)
Table 50. China Globoid Cell Leukodystrophy Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Globoid Cell Leukodystrophy Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Globoid Cell Leukodystrophy Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Globoid Cell Leukodystrophy Treatment Market Share (2019-2020)
Table 54. Japan Globoid Cell Leukodystrophy Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Globoid Cell Leukodystrophy Treatment Market Share by Type (2015-2020)
Table 56. Japan Globoid Cell Leukodystrophy Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Globoid Cell Leukodystrophy Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Globoid Cell Leukodystrophy Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Globoid Cell Leukodystrophy Treatment Market Share (2019-2020)
Table 60. Southeast Asia Globoid Cell Leukodystrophy Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Globoid Cell Leukodystrophy Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Globoid Cell Leukodystrophy Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Globoid Cell Leukodystrophy Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Globoid Cell Leukodystrophy Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Globoid Cell Leukodystrophy Treatment Market Share (2019-2020)
Table 66. India Globoid Cell Leukodystrophy Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Globoid Cell Leukodystrophy Treatment Market Share by Type (2015-2020)
Table 68. India Globoid Cell Leukodystrophy Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Globoid Cell Leukodystrophy Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Globoid Cell Leukodystrophy Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Globoid Cell Leukodystrophy Treatment Market Share (2019-2020)
Table 72. Central & South America Globoid Cell Leukodystrophy Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Globoid Cell Leukodystrophy Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Globoid Cell Leukodystrophy Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Globoid Cell Leukodystrophy Treatment Market Share by Application (2015-2020)
Table 76. Commence Bio Inc Company Details
Table 77. Commence Bio Inc Business Overview
Table 78. Commence Bio Inc Product
Table 79. Commence Bio Inc Revenue in Globoid Cell Leukodystrophy Treatment Business (2015-2020) (Million US$)
Table 80. Commence Bio Inc Recent Development
Table 81. Kyorin Pharmaceutical Co Ltd Company Details
Table 82. Kyorin Pharmaceutical Co Ltd Business Overview
Table 83. Kyorin Pharmaceutical Co Ltd Product
Table 84. Kyorin Pharmaceutical Co Ltd Revenue in Globoid Cell Leukodystrophy Treatment Business (2015-2020) (Million US$)
Table 85. Kyorin Pharmaceutical Co Ltd Recent Development
Table 86. Novartis AG Company Details
Table 87. Novartis AG Business Overview
Table 88. Novartis AG Product
Table 89. Novartis AG Revenue in Globoid Cell Leukodystrophy Treatment Business (2015-2020) (Million US$)
Table 90. Novartis AG Recent Development
Table 91. Nuo Therapeutics Inc Company Details
Table 92. Nuo Therapeutics Inc Business Overview
Table 93. Nuo Therapeutics Inc Product
Table 94. Nuo Therapeutics Inc Revenue in Globoid Cell Leukodystrophy Treatment Business (2015-2020) (Million US$)
Table 95. Nuo Therapeutics Inc Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Globoid Cell Leukodystrophy Treatment Market Share by Type: 2020 VS 2026
Figure 2. RND-001 Features
Figure 3. CMB-200 Features
Figure 4. DUOC-01 Features
Figure 5. Others Features
Figure 6. Global Globoid Cell Leukodystrophy Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Research Center Case Studies
Figure 10. Globoid Cell Leukodystrophy Treatment Report Years Considered
Figure 11. Global Globoid Cell Leukodystrophy Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Globoid Cell Leukodystrophy Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Globoid Cell Leukodystrophy Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Globoid Cell Leukodystrophy Treatment Market Share by Players in 2019
Figure 16. Global Top Globoid Cell Leukodystrophy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Globoid Cell Leukodystrophy Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Globoid Cell Leukodystrophy Treatment Revenue in 2019
Figure 18. North America Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed

以下、関連資料のご紹介
  • 異染性白質ジストロフィー（MLD）治療の世界市場（～2026年）
    Global Metachromatic Leukodystrophy (MLD) Treatment Market Insights and Forecast to 2026
    MRC2-11QY07619 2020年11月20日 118Pages
    当調査資料は異染性白質ジストロフィー（MLD）治療のグローバル市場について調査・分析したレポートです。種類別（AGT-183、DUOC-01、GSK-2696274、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア...
  • 頭頸部扁平上皮がん (HNSCC)治療の世界市場（～2026年）
    Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY04717 2020年11月20日 128Pages
    当調査資料は頭頸部扁平上皮がん (HNSCC)治療のグローバル市場について調査・分析したレポートです。種類別（唾液腺、口腔および中咽頭、鼻腔および副鼻腔、鼻咽頭、喉頭および下咽頭）市場規模、用途別（病院、専門クリニック、外来外科センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フラ...
  • 筋萎縮性側索硬化症（ルーゲーリック病）治療の世界市場（～2026年）
    Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY10827 2020年11月25日 93Pages
    当調査資料は筋萎縮性側索硬化症（ルーゲーリック病）治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、幹細胞治療）市場規模、用途別（病院、診断センター、診療所、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本...
  • 若年性黄斑変性症（シュタルガルト病）治療の世界市場（～2026年）
    Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY12456 2020年11月25日 94Pages
    当調査資料は若年性黄斑変性症（シュタルガルト病）治療のグローバル市場について調査・分析したレポートです。種類別（幹細胞治療、遺伝子治療、その他）市場規模、用途別（病院、眼科クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本...
  • 神経精神障害・治療の世界市場（～2026年）
    Global Neuropsychiatric Disorders And Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY03957 2020年11月20日 97Pages
    当調査資料は神経精神障害・治療のグローバル市場について調査・分析したレポートです。種類別（変性疾患、神経症、精神病）市場規模、用途別（病院、診療所、研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オースト...
  • 多形性膠芽腫（GBM）治療の世界市場（～2026年）
    Global Glioblastoma Multiforme Treatment (GBM) Market Size, Status and Forecast 2020-2026
    MRC2-11QY12056 2020年11月25日 92Pages
    当調査資料は多形性膠芽腫（GBM）治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、放射線療法、遺伝子治療、分子バイオテクノロジー）市場規模、用途別（ベバコズマブ、カルムスチン、テモゾロミド）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリ...
  • HIV診断・治療の世界市場（～2026年）
    Global HIV Diagnosis & Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY12200 2020年11月25日 95Pages
    当調査資料はHIV診断・治療のグローバル市場について調査・分析したレポートです。種類別（ELISA検査、唾液検査、ウイルス量検査、ウエスタンブロット、その他）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日...
  • 癲癇診断・治療の世界市場（～2026年）
    Global Epilepsy Diagnosis & Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY11874 2020年11月25日 91Pages
    当調査資料は癲癇診断・治療のグローバル市場について調査・分析したレポートです。種類別（診断（神経学的検査・血液検査・画像診断）、治療（医学・手術））市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、...
  • 経口血糖降下薬（OAD）治療の世界市場（～2026年）
    Global Oral Antidiabetic (OAD) Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY04077 2020年11月20日 99Pages
    当調査資料は経口血糖降下薬（OAD）治療のグローバル市場について調査・分析したレポートです。種類別（スルホニル尿素剤、ビグアニド、腸内α-グルコシダーゼ阻害剤、その他）市場規模、用途別（病院、クリニック、糖尿病治療センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、...
  • 髄膜炎診断・治療の世界市場（～2026年）
    Global Meningitis Diagnosis and Treatment Market Size, Status and Forecast 2020-2026
    MRC2-11QY12650 2020年11月25日 91Pages
    当調査資料は髄膜炎診断・治療のグローバル市場について調査・分析したレポートです。種類別（血液培養、イメージング、腰椎穿刺）市場規模、用途別（病院・クリニック、診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド...
  • 異染性白質ジストロフィー（MLD）治療の世界市場（～2026年）異染性白質ジストロフィー（MLD）治療の世界市場（～2026年） Market Analysis and Insights: Global Metachromatic Leukodystrophy (MLD) Treatment Market The global Metachromatic Leukodystrophy (MLD) Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Metachromatic Leukodystro…
  • 巨細胞性動脈炎治療の世界市場（～2026年）巨細胞性動脈炎治療の世界市場（～2026年） Giant cell arteritis is also known as temporal arteritis, is a type of disease which causes inflammation of medium and large vessels that occurs only in individuals older than 50 years of age. Seasonal variations in the incidence of giant cell arteritis treatment suggest a possible infective origin …
  • 小細胞肺がん治療の世界市場（～2026年）小細胞肺がん治療の世界市場（～2026年） Market Analysis and Insights: Global Small Cell Lung Cancer Treatment Market The global Small Cell Lung Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Small Cell Lung Cancer Treatment Scope and Market…
  • 形質細胞新生物治療の世界市場（～2026年）形質細胞新生物治療の世界市場（～2026年） Plasma cell neoplasms are diseases in which the body makes too many plasma cells. The plasma cells also make an antibody protein, called M protein, that is not needed by the body and does not help fight infection. These antibody proteins build up in the bone marrow and can cause the blood to thicken…
  • 有毛細胞白血病治療の世界市場（～2026年）有毛細胞白血病治療の世界市場（～2026年） Hairy cell leukemia is a rare type of cancer of blood which is caused due to abnormal growth of B cells. It has been observed that out of all the leukemia’s, hairy cell leukemia accounts for about 2% and thus eventually must be treated after its prominent symptoms. The drivers for the HCL market can…